ZA785335B - Xanthine derivatives - Google Patents

Xanthine derivatives

Info

Publication number
ZA785335B
ZA785335B ZA00785335A ZA785335A ZA785335B ZA 785335 B ZA785335 B ZA 785335B ZA 00785335 A ZA00785335 A ZA 00785335A ZA 785335 A ZA785335 A ZA 785335A ZA 785335 B ZA785335 B ZA 785335B
Authority
ZA
South Africa
Prior art keywords
xanthine derivatives
xanthine
derivatives
Prior art date
Application number
ZA00785335A
Other languages
English (en)
Inventor
L Sorenby
P Kjellin
S Bergstrand
C Persson
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of ZA785335B publication Critical patent/ZA785335B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00785335A 1977-10-14 1978-09-19 Xanthine derivatives ZA785335B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (1)

Publication Number Publication Date
ZA785335B true ZA785335B (en) 1979-09-26

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00785335A ZA785335B (en) 1977-10-14 1978-09-19 Xanthine derivatives

Country Status (21)

Country Link
US (1) US4233303A (xx)
EP (1) EP0001735B1 (xx)
JP (1) JPS5479296A (xx)
AT (1) AT363491B (xx)
AU (1) AU521585B2 (xx)
CA (1) CA1109470A (xx)
CS (1) CS208756B2 (xx)
DD (1) DD139855A5 (xx)
DE (1) DE2862017D1 (xx)
DK (1) DK148260C (xx)
FI (1) FI66383C (xx)
HK (1) HK6385A (xx)
HU (1) HU180219B (xx)
IE (1) IE47884B1 (xx)
IT (1) IT1109208B (xx)
NO (1) NO147562C (xx)
NZ (1) NZ188566A (xx)
SE (1) SE416810C (xx)
SG (1) SG85584G (xx)
SU (1) SU755199A3 (xx)
ZA (1) ZA785335B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
WO2004096228A1 (en) 2003-04-25 2004-11-11 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
CN101094671A (zh) * 2004-04-16 2007-12-26 美国诺华卡迪亚公司 包含腺苷a1受体拮抗剂和醛固酮抑制剂的组合疗法
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
FI783126A (fi) 1979-04-15
DD139855A5 (de) 1980-01-23
FI66383B (fi) 1984-06-29
DK148260C (da) 1986-02-10
HK6385A (en) 1985-02-01
US4233303A (en) 1980-11-11
JPS5479296A (en) 1979-06-25
SE416810B (sv) 1981-02-09
IT7851499A0 (it) 1978-10-13
EP0001735B1 (en) 1982-09-01
DK453778A (da) 1979-04-15
EP0001735A1 (en) 1979-05-02
IT1109208B (it) 1985-12-16
NZ188566A (en) 1984-07-06
SE7711581L (sv) 1979-04-15
ATA714478A (de) 1980-09-15
SG85584G (en) 1985-06-07
AT363491B (de) 1981-08-10
CS208756B2 (en) 1981-09-15
CA1109470A (en) 1981-09-22
HU180219B (en) 1983-02-28
SU755199A3 (en) 1980-08-07
NO147562B (no) 1983-01-24
DK148260B (da) 1985-05-20
AU521585B2 (en) 1982-04-22
IE47884B1 (en) 1984-07-11
NO147562C (no) 1983-05-18
IE782041L (en) 1979-04-14
SE416810C (sv) 1982-07-19
NO783471L (no) 1979-04-18
AU4036578A (en) 1980-04-17
FI66383C (fi) 1984-10-10
DE2862017D1 (en) 1982-10-28

Similar Documents

Publication Publication Date Title
IL55387A0 (en) Triphenylalkene derivatives
ZA785335B (en) Xanthine derivatives
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876B (en) Beta-haloethylamine derivatives
PH12853A (en) Meta-sulfonamido-benzamide derivatives
GB2006188B (en) Purine derivatives
GB2008579B (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
GB2009180B (en) 25-alkylcholestrerol derivatives
GB2009150B (en) Tetrahydrophtalamide derivatives
MY8400370A (en) Prostanol derivatives
GB2005261B (en) 2-oxazolydone derivatives
PH13915A (en) Chinazoline derivatives
IL56042A0 (en) Prostanglandin derivatives
GB2014131B (en) 1-hydrocarbylpyrrole derivatives
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
AU3313978A (en) Everninomicin derivatives
NZ188863A (en) 2-oxo-hexahydroazepine -piperidine and -pyrrolidine derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
GB2008119B (en) Arylsteroid derivatives
GB1547214A (en) Purine derivatives
AU4129978A (en) Eburnamenine derivatives
IL54973A0 (en) 3-pyridylhydroxy-prop-1-ene derivatives
GB2003855B (en) Triphenylbut-1-ene derivatives